ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.695
      -0.11%
      Bitcoin
      64,841.09
      -0.46%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. AbbVie Inc (ABBV)

      7. AbbVie Inc (ABBV) News

      ABBV

      AbbVie (ABBV)

      AbbVie Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:ABBV
      DateTimeSourceHeadlineSymbolCompany
      03/01/20244:20PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABBVAbbVie Inc
      02/29/20246:06PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABBVAbbVie Inc
      02/29/20245:33PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABBVAbbVie Inc
      02/29/20244:04PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABBVAbbVie Inc
      02/28/202412:05AMPR Newswire (US)AbbVie and OSE Immunotherapeutics Announce Partnership to Develop a Novel Monoclonal Antibody for the Treatment of Chronic InflammationNYSE:ABBVAbbVie Inc
      02/27/20245:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABBVAbbVie Inc
      02/27/20248:00AMGlobeNewswire Inc.Healis Therapeutics' asset CKDB-501A shares Phase III topline results for glabellar injections from CKD Bio in South KoreaNYSE:ABBVAbbVie Inc
      02/27/20248:00AMPR Newswire (US)AbbVie to Present at the TD Cowen 44th Annual Health Care ConferenceNYSE:ABBVAbbVie Inc
      02/27/20247:45AMPR Newswire (US)U.S. Food and Drug Administration (FDA) Grants Priority Review of Epcoritamab (EPKINLY®) for Difficult-to-Treat Relapsed or Refractory Follicular Lymphoma (FL)NYSE:ABBVAbbVie Inc
      02/26/20245:08PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ABBVAbbVie Inc
      02/26/20246:12AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:ABBVAbbVie Inc
      02/23/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABBVAbbVie Inc
      02/23/20244:04PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABBVAbbVie Inc
      02/22/20248:05AMPR Newswire (US)AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics for Oncology and ImmunologyNYSE:ABBVAbbVie Inc
      02/21/20246:00PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABBVAbbVie Inc
      02/21/20248:39AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:ABBVAbbVie Inc
      02/21/20248:00AMPR Newswire (US)BOTOX® Cosmetic (onabotulinumtoxinA) Announces Its 2024 Grant Program Supporting Women EntrepreneursNYSE:ABBVAbbVie Inc
      02/20/20245:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABBVAbbVie Inc
      02/20/20245:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABBVAbbVie Inc
      02/20/20245:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABBVAbbVie Inc
      02/20/20245:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABBVAbbVie Inc
      02/20/20245:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABBVAbbVie Inc
      02/20/20245:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABBVAbbVie Inc
      02/20/20245:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABBVAbbVie Inc
      02/20/20245:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABBVAbbVie Inc
      02/20/20245:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABBVAbbVie Inc
      02/20/20245:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABBVAbbVie Inc
      02/20/20249:00AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ABBVAbbVie Inc
      02/20/20249:00AMPR Newswire (US)AbbVie Announces Appointment of Robert A. Michael as Chief Executive OfficerNYSE:ABBVAbbVie Inc
      02/19/20248:30AMPR Newswire (US)AbbVie Unveils New Data from Robust Gastroenterology Portfolio at the 19th Congress of European Crohn's and Colitis Organisation (ECCO)NYSE:ABBVAbbVie Inc
       Showing the most relevant articles for your search:NYSE:ABBV